The genomically-adjusted radiation dose (GARD) can predict risk of local tumor recurrence and optimize radiation dose

Leaders in BRCA research say screening recommendations from the US Preventive Services Task Force are a positive step forward, but testing of individuals with the highest risk must improve

New reusable device uses carbon dioxide to power a cancer tissue-freezing probe instead of industry-standard argon

City of Hope scientists are trying to change how doctors treat patients with solid tumors

CMS has reopened it's decision on next-generation sequencing in patients with advanced cancers

Researchers found that the previous assumption that a greater diversity of tumor cells was present in more aggressive tumors was false

Study finds 21-gene assay was associated with savings of approximately $3,600 per patient in chemotherapy costs alone for people with high-risk breast cancer

De-escalation of treatment strategies aims to minimize toxicity while maintaining efficacy

Compared to women ages 40 to 44 at average risk, incidence screening of women in their 30s with at least one of the three evaluated risk factors showed similar cancer detection rates

Adaptive design offers benefits over randomized controlled trials